U.S. markets closed
  • S&P Futures

    4,529.00
    +4.75 (+0.10%)
     
  • Dow Futures

    34,953.00
    +43.00 (+0.12%)
     
  • Nasdaq Futures

    15,060.75
    +27.25 (+0.18%)
     
  • Russell 2000 Futures

    2,061.50
    +2.30 (+0.11%)
     
  • Crude Oil

    86.00
    -0.96 (-1.10%)
     
  • Gold

    1,842.70
    -0.50 (-0.03%)
     
  • Silver

    24.17
    -0.06 (-0.25%)
     
  • EUR/USD

    1.1364
    +0.0017 (+0.15%)
     
  • 10-Yr Bond

    1.8270
    -0.0380 (-2.04%)
     
  • Vix

    23.85
    +1.06 (+4.65%)
     
  • GBP/USD

    1.3630
    +0.0018 (+0.13%)
     
  • USD/JPY

    114.1800
    -0.1730 (-0.15%)
     
  • BTC-USD

    41,787.50
    -587.17 (-1.39%)
     
  • CMC Crypto 200

    990.97
    -3.78 (-0.38%)
     
  • FTSE 100

    7,589.66
    +26.11 (+0.35%)
     
  • Nikkei 225

    27,497.53
    +30.30 (+0.11%)
     

U.S. Ready to Expedite Omicron-Specific Vaccine, If Needed

·3 min read
U.S. Ready to Expedite Omicron-Specific Vaccine, If Needed
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Regulators "will move swiftly" to streamline the authorization process if new vaccines are developed to fight the Omicron variant, CDC Director Dr. Rochelle Walensky told ABC’s "This Week."